Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

In vivo modulation of the behavioral effects of nicotine by the coumarins xanthotoxin, bergapten, and umbelliferone.

Budzynska B, Skalicka-Wozniak K, Kruk-Slomka M, Wydrzynska-Kuzma M, Biala G.

Psychopharmacology (Berl). 2016 Jun;233(12):2289-300. doi: 10.1007/s00213-016-4279-9. Epub 2016 Apr 14.

2.

Influences of barriers to cessation and reasons for quitting on substance use among treatment-seeking smokers who report heavy drinking.

Foster DW, Schmidt NB, Zvolensky MJ.

J Addict Res Ther. 2015 Dec;6(4). pii: 246. Epub 2015 Oct 15.

PMID:
26949566
3.

Effect of Abstinence on Audio-Visual Reaction Time in Chronic Smokers Pursuing a Professional Course.

Vallath AL, Joshi AR, Vaidya SM.

J Clin Diagn Res. 2015 Dec;9(12):CC08-11. doi: 10.7860/JCDR/2015/14696.6973. Epub 2015 Dec 1.

4.

nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.

Parikh V, Kutlu MG, Gould TJ.

Schizophr Res. 2016 Mar;171(1-3):1-15. doi: 10.1016/j.schres.2016.01.020. Epub 2016 Jan 21. Review.

PMID:
26803692
5.

Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans.

Olfson E, Saccone NL, Johnson EO, Chen LS, Culverhouse R, Doheny K, Foltz SM, Fox L, Gogarten SM, Hartz S, Hetrick K, Laurie CC, Marosy B, Amin N, Arnett D, Barr RG, Bartz TM, Bertelsen S, Borecki IB, Brown MR, Chasman DI, van Duijn CM, Feitosa MF, Fox ER, Franceschini N, Franco OH, Grove ML, Guo X, Hofman A, Kardia SL, Morrison AC, Musani SK, Psaty BM, Rao DC, Reiner AP, Rice K, Ridker PM, Rose LM, Schick UM, Schwander K, Uitterlinden AG, Vojinovic D, Wang JC, Ware EB, Wilson G, Yao J, Zhao W, Breslau N, Hatsukami D, Stitzel JA, Rice J, Goate A, Bierut LJ.

Mol Psychiatry. 2016 May;21(5):601-7. doi: 10.1038/mp.2015.105. Epub 2015 Aug 4.

PMID:
26239294
6.

Developmental Neurotoxicity of Tobacco Smoke Directed Toward Cholinergic and Serotonergic Systems: More Than Just Nicotine.

Slotkin TA, Skavicus S, Card J, Stadler A, Levin ED, Seidler FJ.

Toxicol Sci. 2015 Sep;147(1):178-89. doi: 10.1093/toxsci/kfv123. Epub 2015 Jun 16.

PMID:
26085346
7.

Pathways and networks-based analysis of candidate genes associated with nicotine addiction.

Liu M, Fan R, Liu X, Cheng F, Wang J.

PLoS One. 2015 May 12;10(5):e0127438. doi: 10.1371/journal.pone.0127438. eCollection 2015.

8.

Tobacco use in bipolar disorder.

Thomson D, Berk M, Dodd S, Rapado-Castro M, Quirk SE, Ellegaard PK, Berk L, Dean OM.

Clin Psychopharmacol Neurosci. 2015 Apr 30;13(1):1-11. doi: 10.9758/cpn.2015.13.1.1.

9.

Mephedrone and nicotine: oxidative stress and behavioral interactions in animal models.

Budzynska B, Boguszewska-Czubara A, Kruk-Slomka M, Kurzepa J, Biala G.

Neurochem Res. 2015 May;40(5):1083-93. doi: 10.1007/s11064-015-1566-5. Epub 2015 Apr 11.

10.

Varenicline enhances dopamine release facilitation more than nicotine after long-term nicotine treatment and withdrawal.

Perez XA, Khroyan TV, McIntosh JM, Quik M.

Pharmacol Res Perspect. 2015 Feb;3(1):e00105. doi: 10.1002/prp2.105. Epub 2014 Dec 16.

11.

Activities of nicotinic acetylcholine receptors modulate neurotransmission and synaptic architecture.

Oda A, Tanaka H.

Neural Regen Res. 2014 Dec 15;9(24):2128-31. doi: 10.4103/1673-5374.147943. Review.

12.

Prenatal nicotine alters the developmental neurotoxicity of postnatal chlorpyrifos directed toward cholinergic systems: better, worse, or just "different?".

Slotkin TA, Seidler FJ.

Brain Res Bull. 2015 Jan;110:54-67. doi: 10.1016/j.brainresbull.2014.12.003. Epub 2014 Dec 12.

13.

Waterpipe tobacco smoking: what is the evidence that it supports nicotine/tobacco dependence?

Aboaziza E, Eissenberg T.

Tob Control. 2015 Mar;24 Suppl 1:i44-i53. doi: 10.1136/tobaccocontrol-2014-051910. Epub 2014 Dec 9. Review.

14.

Conditioned place preference and self-administration induced by nicotine in adolescent and adult rats.

Ahsan HM, de la Peña JB, Botanas CJ, Kim HJ, Yu GY, Cheong JH.

Biomol Ther (Seoul). 2014 Sep;22(5):460-6. doi: 10.4062/biomolther.2014.056. Epub 2014 Sep 30.

15.

Contributions of β2 subunit-containing nAChRs to chronic nicotine-induced alterations in cognitive flexibility in mice.

Cole RD, Poole RL, Guzman DM, Gould TJ, Parikh V.

Psychopharmacology (Berl). 2015 Apr;232(7):1207-17. doi: 10.1007/s00213-014-3754-4. Epub 2014 Oct 4.

16.

Varenicline: A review of the literature and place in therapy.

Whitley HP, Moorman KL.

Pharm Pract (Granada). 2007 Apr;5(2):51-8.

17.

Nicotine and methamphetamine disrupt habituation of sensory reinforcer effectiveness in male rats.

Lloyd DR, Hausknecht KA, Richards JB.

Exp Clin Psychopharmacol. 2014 Apr;22(2):166-75. doi: 10.1037/a0034741.

18.

Interactive effects of chronic cigarette smoking and age on hippocampal volumes.

Durazzo TC, Meyerhoff DJ, Nixon SJ.

Drug Alcohol Depend. 2013 Dec 1;133(2):704-11. doi: 10.1016/j.drugalcdep.2013.08.020. Epub 2013 Sep 2.

19.

Influence of acute or chronic calcium channel antagonists on the acquisition and consolidation of memory and nicotine-induced cognitive effects in mice.

Biala G, Kruk-Slomka M, Jozwiak K.

Naunyn Schmiedebergs Arch Pharmacol. 2013 Jul;386(7):651-64. doi: 10.1007/s00210-013-0866-z. Epub 2013 Apr 12.

20.

Effects of COMT genotype on sensory gating and its modulation by nicotine: Differences in low and high P50 suppressors.

de la Salle S, Smith D, Choueiry J, Impey D, Philippe T, Dort H, Millar A, Albert P, Knott V.

Neuroscience. 2013 Jun 25;241:147-56. doi: 10.1016/j.neuroscience.2013.03.029. Epub 2013 Mar 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk